POZEN Inc (POZN.OQ)

POZN.OQ on NASDAQ Stock Exchange Global Select Market

8.00USD
22 Sep 2014
Price Change (% chg)

$0.11 (+1.39%)
Prev Close
$7.89
Open
$7.83
Day's High
$8.03
Day's Low
$7.76
Volume
61,355
Avg. Vol
72,870
52-wk High
$9.73
52-wk Low
$4.38

POZN.OQ

Chart for POZN.OQ

About

POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet... (more)

Overall

Beta: 2.12
Market Cap (Mil.): $248.76
Shares Outstanding (Mil.): 31.53
Dividend: 1.75
Yield (%): --

Financials

  POZN.OQ Industry Sector
P/E (TTM): -- 144.58 33.70
EPS (TTM): -0.05 -- --
ROI: -1.99 -2.25 17.35
ROE: -1.99 -6.85 18.21
Search Stocks

Pernix to buy U.S. marketing rights to GSK, Pozen migraine drug

- Pernix Therapeutics Holdings Inc said it would buy the U.S. marketing rights for a migraine treatment developed by GlaxoSmithKline Plc and Pozen Inc for an upfront payment of $250 million.

14 May 2014

Competitors

  Price Change
Pfizer Inc. (PFE.N) $30.18 -0.22
Merck & Co., Inc. (MRK.N) $60.58 +0.09

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks